Stock FAQs

abiomed historic stock price

by Dr. Van Grant II Published 3 years ago Updated 2 years ago

What is the stock price for Abiomed?

Historical daily share price chart and data for ABIOMED since 1987 adjusted for splits. The latest closing stock price for ABIOMED as of February 18, 2022 is 298.38.

What is Abiomed’s all-time high?

The all-time high ABIOMED stock closing price was 449.75 on September 28, 2018. The ABIOMED 52-week high stock price is 379.30, which is 27.1% above the current share price.

What is the AbioMed 52-week high and low prices?

The ABIOMED 52-week high stock price is 379.30, which is 27.1% above the current share price. The ABIOMED 52-week low stock price is 261.27, which is 12.4% below the current share price.

What is Abiomed known for?

Abiomed Inc. ABIOMED, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It distributes its products under the Impella brand. The company was founded in 1981 and is headquartered in Danvers, MA.

Is Abiomed stock a buy?

Out of 4 analysts, 1 (25%) are recommending ABMD as a Strong Buy, 0 (0%) are recommending ABMD as a Buy, 2 (50%) are recommending ABMD as a Hold, 0 (0%) are recommending ABMD as a Sell, and 1 (25%) are recommending ABMD as a Strong Sell.

Is Abiomed publicly traded?

Abiomed is a publicly-traded medical devices company that develops and manufactures external and implantable circulatory support devices.

When did Abiomed go public?

1987: Applied Biomedical is merged into newly formed Abiomed, which is taken public. 1994: The National Institutes of Health (NIH) selects company to receive funding for final stage of artificial heart development.

Who is the CEO of Abiomed?

Michael R. Minogue (Apr 6, 2004–)Abiomed / CEO

Here's Why You Should Retain Abiomed (ABMD) Stock For Now

Abiomed to Present at the SVB Leerink 11th Annual Global Healthcare Conference

Investors remain optimistic about Abiomed (ABMD) due to strength in its Impella product line.

Abiomed (ABMD) Beats on Q3 Earnings, Narrows FY22 Guidance

DANVERS, Mass., February 08, 2022--Abiomed to present at the SVB Leerink 11th Annual Global Healthcare conference.

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 1 2 3 4 5 6 7 8 9